Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Weight Loss May Improve Outcomes in Ewing Sarcoma Patients.

Created on 04 Nov 2026

Authors

Yair Peled, Dror Levin, Michal Manisterski, Maayan Siri, Natanya Kollender, Ronit Elhasid, Neta Nevo

Published in

Journal of pediatric hematology/oncology. Nov 04, 2026. Epub Nov 04, 2026.

Abstract

Ewing sarcoma (ES) is an aggressive cancer in which the histologic response to neoadjuvant chemotherapy is a key prognostic factor. This study investigated the correlation between weight loss and chemotherapy response in 57 pediatric patients with ES.
A significant, direct correlation (P=0.008) was found between weight loss and a good chemotherapy response: 93% of patients with ≥3% weight loss had a good response, compared with only 40% of those without.
This may suggest that caloric restriction mimics the effects observed in other cancers, potentially reducing tumor proliferation and angiogenesis.

PMID:
42980493
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement